Posted by Michael Wonder on 03 May 2021
How the FDA’s ‘master plan’ will affect NIH funding for digital medicine projects
3 May 2021 - The term B.C. took on a new meaning — Before COVID — last year when almost everything we knew changed.
Among those changes is the way health care research and development are being conducted after the way COVID-19 vaccines were developed and brought to market.
While it’s true that a good deal of research on the use of mRNA technology — the secret sauce in two of the COVID-19 vaccines authorised so far in the U.S. — is more than a decade old, the speed with which those vaccines were developed and authorised for widespread use was unprecedented.
